Ocular hypotensive efficacy and safety of brinzolamide ophthalmic suspension 1% added to travoprost ophthalmic solution 0.004% therapy in patients with openangle glaucoma or ocular hypertension

By Franks Wendy    

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1643-1649

Informa Healthcare

Access to resources Recommend Favorite

Brinzolamide 1%/timolol 0.5%: safety and efficacy of a new fixed-combination IOP-lowering product for glaucoma

By Januleviciene Ingrida  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2575-2578

Informa Healthcare

Access to resources Recommend Favorite

Comparison of morning versus evening dosing and 24-h post-dose efficacy of travoprost compared with latanoprost in patients with open-angle glaucoma**

By Yan David B.   Battista Robert A.   Haidich Anna-Bettina   Konstas Anastasios G. P.  

Current Medical Research and Opinion, Vol. 24, Iss. 11, 2008-11 ,pp. : 3023-3027

Informa Healthcare

Access to resources Recommend Favorite

Ocular hypotensive efficacy of travoprost in patients unsuccessfully treated with latanoprost

By Kaback Martin   Geanon John   Katz Gregory   Ripkin Douglas   Przydryga Johan    

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1341-1345

Informa Healthcare

Access to resources Recommend Favorite

Evaluation of circadian control of intraocular pressure after a single drop of bimatoprost 0.03% or travoprost 0.004%

By Frenkel Ronald E.   Noecker Robert J.   Craven E. Randy  

Current Medical Research and Opinion, Vol. 24, Iss. 4, 2008-04 ,pp. : 919-923

Informa Healthcare

Access to resources Recommend Favorite